Exelixis Inc. is a biopharmaceutical company that specializes in the discovery, development, and commercialization of targeted therapies for the treatment of cancer. With a focus on precision medicine, the company’s innovative approach has yielded successful treatments for a variety of cancers, providing hope for patients worldwide.
